These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


211 related items for PubMed ID: 36672649

  • 1. Extracorporeal Carbon Dioxide Removal: From Pathophysiology to Clinical Applications; Focus on Combined Continuous Renal Replacement Therapy.
    Cappadona F, Costa E, Mallia L, Sangregorio F, Nescis L, Zanetti V, Russo E, Bianzina S, Viazzi F, Esposito P.
    Biomedicines; 2023 Jan 05; 11(1):. PubMed ID: 36672649
    [Abstract] [Full Text] [Related]

  • 2. Combined extracorporeal CO2 removal and renal replacement therapy in a pregnant patient with COVID-19: a case report.
    Esposito P, Cappadona F, Sangregorio F, Costa E, Mallia L, Zanetti V, Nescis L, Bianzina S, Ferrari F, Patroniti NA, Traverso GB, Viazzi F.
    G Ital Nefrol; 2023 Apr 27; 40(2):. PubMed ID: 37179478
    [Abstract] [Full Text] [Related]

  • 3. Application of extracorporeal carbon dioxide removal combined with continuous blood purification therapy in ARDS with hypercapnia in patients with critical COVID-19.
    Chen Y, Wang S, Huang J, Fu Y, Wen J, Zhou C, Fu Y, Liu L.
    Clin Hemorheol Microcirc; 2021 Apr 27; 78(2):199-207. PubMed ID: 33554895
    [Abstract] [Full Text] [Related]

  • 4. Feasibility and safety of low-flow extracorporeal CO2 removal managed with a renal replacement platform to enhance lung-protective ventilation of patients with mild-to-moderate ARDS.
    Schmidt M, Jaber S, Zogheib E, Godet T, Capellier G, Combes A.
    Crit Care; 2018 May 10; 22(1):122. PubMed ID: 29743094
    [Abstract] [Full Text] [Related]

  • 5. Minimal-flow ECCO2R in patients needing CRRT does not facilitate lung-protective ventilation.
    Moerer O, Harnisch LO, Barwing J, Heise D, Heuer JF, Quintel M.
    J Artif Organs; 2019 Mar 10; 22(1):68-76. PubMed ID: 30284167
    [Abstract] [Full Text] [Related]

  • 6. Extracorporeal Carbon Dioxide Removal Using a Renal Replacement Therapy Platform to Enhance Lung-Protective Ventilation in Hypercapnic Patients With Coronavirus Disease 2019-Associated Acute Respiratory Distress Syndrome.
    Husain-Syed F, Birk HW, Wilhelm J, Ronco C, Ranieri VM, Karle B, Kuhnert S, Tello K, Hecker M, Morty RE, Herold S, Kehl O, Walmrath HD, Seeger W, Vadász I.
    Front Med (Lausanne); 2020 Mar 10; 7():598379. PubMed ID: 33304914
    [Abstract] [Full Text] [Related]

  • 7. A preliminary cost-effectiveness analysis of lung protective ventilation with extra corporeal carbon dioxide removal (ECCO2R) in the management of acute respiratory distress syndrome (ARDS).
    Ethgen O, Goldstein J, Harenski K, Mekontso Dessap A, Morimont P, Quintel M, Combes A.
    J Crit Care; 2021 Jun 10; 63():45-53. PubMed ID: 33618281
    [Abstract] [Full Text] [Related]

  • 8. Extracorporeal carbon dioxide removal (ECCO2R) in COPD and ARDS patients with severe hypercapnic respiratory failure. A retrospective case-control study.
    İnal V, Efe S.
    Turk J Med Sci; 2021 Aug 30; 51(4):2127-2135. PubMed ID: 33932971
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lung (extracorporeal CO2 removal) and renal (continuous renal replacement therapy) support: the role of ultraprotective strategy in Covid 19 and non-Covid 19 ARDS. A case-control study.
    Pasero D, Pistidda L, Piredda D, Liperi C, Cossu A, Esposito R, Muroni A, Mereu C, Rum C, Branca GP, Mulas F, Puci M, Sotgiu G, Terragni P.
    J Anesth Analg Crit Care; 2024 Apr 27; 4(1):27. PubMed ID: 38671540
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Feasibility and safety of low-flow extracorporeal carbon dioxide removal to facilitate ultra-protective ventilation in patients with moderate acute respiratory distress sindrome.
    Fanelli V, Ranieri MV, Mancebo J, Moerer O, Quintel M, Morley S, Moran I, Parrilla F, Costamagna A, Gaudiosi M, Combes A.
    Crit Care; 2016 Feb 10; 20():36. PubMed ID: 26861596
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Extracorporeal Carbon Dioxide Removal During Continuous Renal Replacement Therapy as Adjunctive Therapy.
    Jacobs R, Sablon A, Spapen H.
    Respir Care; 2020 Apr 10; 65(4):517-524. PubMed ID: 32213601
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of the safety and efficacy of extracorporeal carbon dioxide removal in the critically ill using the PrismaLung+ device.
    Tiruvoipati R, Ludski J, Gupta S, Subramaniam A, Ponnapa Reddy M, Paul E, Haji K.
    Eur J Med Res; 2023 Aug 18; 28(1):291. PubMed ID: 37596670
    [Abstract] [Full Text] [Related]

  • 19. Safety and Efficacy of Combined Extracorporeal CO2 Removal and Renal Replacement Therapy in Patients With Acute Respiratory Distress Syndrome and Acute Kidney Injury: The Pulmonary and Renal Support in Acute Respiratory Distress Syndrome Study.
    Allardet-Servent J, Castanier M, Signouret T, Soundaravelou R, Lepidi A, Seghboyan JM.
    Crit Care Med; 2015 Dec 18; 43(12):2570-81. PubMed ID: 26488219
    [Abstract] [Full Text] [Related]

  • 20. A Case of the Use of Extracorporeal Carbon Dioxide Removal in a Patient With COVID-19 Acute Respiratory Distress Syndrome.
    Firzli TR, Sathappan S, Siddiqui F.
    Cureus; 2022 May 18; 14(5):e24645. PubMed ID: 35663663
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.